Is neuropathic ulceration the key to understanding increased mortality due to ischaemic heart disease in diabetic foot ulcer patients? A population approach using a proportionate model

Journal of International Medical Research

Volumn 30, Issue 6, 2002, Pages 553-559

  Chammas, N K ^a,b   Hill, R L R ^b   Foster, A V M ^a   Edmonds, M E ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diabetes mellitus; Diabetic foot ulcers; Increased mortality; Ischaemic heart disease; Neuropathic ulceration

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CALCULATION; CAUSE OF DEATH; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DYING; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORTALITY; NEUROPATHY; POPULATION MODEL; PREDICTION;

EID: 0036867491     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000203000602     Document Type: Article

References (14)

1. Nelzen O, Bergqvist D, Lindhagen A: Long-term prognosis for patients with chronic ulcers: a prospective cohort study. Eur J Vasc Endovasc Surg 1997; 13: 500-508.
2. Challeton JP, Letanoux M, Melki JP, Mourad JJ, Priollet P: Le peid diabétique dans une série de 75 patients (in French). Rev Med Interne 1993; 14: 1036.
3. Klamer TW, Towne JB, Banyk D, Bonner MJ: The influence of sepsis and ischaemia on the natural history of the diabetic foot. Am Surg 1987; 53: 490-494.
4. Boyko EJ, Ahroni JH, Smith DG, Davignon D: Increased mortality associated with diabetic foot ulcer. Diabet Med 1996: 13: 967-972.
5. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention trial. Diabetes Care 1993; 16: 434-444.
6. Chammas NK, Hill R, Foster A, Edmonds M: What is the major cause of death for diabetic foot ulcer patients and is it related to the type of ulcer? (Abstract). Diabet Med 2000; 147 (Suppl 1): 53.
7. Hansson C, Andersson E, Swanbeck G: A follow-up study of leg and foot ulcer patients. Acta Derm Venereol 1987; 67: 496-500.
8. Young MJ, Breddy JL, Veves A, Boulton AJ: The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994; 17: 557-560.
9. Johnson WO, Gastwirth JL, Pearson LM: Screening without a 'Gold Standard': the Hui-Walter paradigm revisted. Am J Epidemiol 2001; 153: 921-924.
10. Chilton L, Stansfield H, Tomlinson DR: Neurotrophin receptor p75 as a plasma marker for diabetic neuropathy (Abstract). Diabetic Med 2002; 19 (Suppl 2): 239.
11. Huang ES, Meigs JB, Singer DS: The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med 2001; 111: 633-642.
12. Meinhold JA, Maslowska-Wessel E, Bender R, Sawicki PT: Low prevalence of cardiac autonomic neuropathy in Type I diabetic patients without neuropathy. Diabet Med 2001; 18: 607-613.
13. Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A: Role of neuropathy and high foot pressure in diabetic foot ulceration. Diabetes Care 1998; 21: 1714-1719.
14. Mantey I, Hill RLR, Foster AVM, Wilson S, Wade JJ, Edmonds ME: Infection of foot ulcers with Staphylococcus aureus associated with increased mortality in diabetic patients. Commun Dis Public Health 2000; 3: 288-290.